Breaks Categories: News

WednesdayJul 16, 2025 9:30 am

NetworkNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025

BioAdaptives (OTC Pink: BDPT), a wellness innovator, announced the national rollout of NeuroRush(TM), its next-generation nootropic aimed at enhancing mental clarity, cognitive endurance, and stress adaptability. Following strong results in test markets, the adaptogen-based formula will launch in August/September 2025 in two versions—one with natural caffeine and one caffeine-free. Formulated with clinically studied ingredients like Rhodiola, Ashwagandha, and Bacopa, NeuroRush(TM) supports brain health without the crash of stimulants. The product will be available online and through strategic wellness partners. To view the full press release, visit https://nnw.fm/I3jid About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the…

Continue Reading

WednesdayJul 16, 2025 9:00 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights August as Key Window for Commercial EV Incentives Through Bollinger Motors

Mullen Automotive (NASDAQ: MULN), through its subsidiary Bollinger Motors, announced that August will present a prime opportunity to purchase commercial EVs as New York’s Truck Voucher Incentive Program (NYTVIP) is set to be replenished. The program offers up to $144,000 in point-of-sale vouchers, which, when combined with the federal 45W tax credit of up to $40,000 for Class 4 vehicles, delivers major upfront savings. With federal credits expiring after September 30, 2025, Bollinger urges fleet operators to act swiftly. The Bollinger B4, an all-electric Class 4 chassis cab, qualifies for these programs and is engineered for performance, safety, and urban…

Continue Reading

TuesdayJul 15, 2025 2:30 pm

NetworkNewsBreaks – Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming ‘Key Catalysts’

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research report that presented a favorable analysis, noting that the company is anticipating a number of key catalysts in the second half of 2025, including progress on its current phase 3 FLASH2 trial of HyBryte(TM) for the treatment of early-stage cutaneous T cell lymphoma (“CTCL”). According to the report, Soligenix is developing products to treat rare diseases within two business segments: Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics business segment currently has multiple products under development, and the report noted…

Continue Reading

TuesdayJul 15, 2025 12:50 pm

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) Partners With Data Specialties Inc. to Accelerate Modular AI Data Center Deployment 

BluSky AI (OTC: BSAI), a leader in modular AI data infrastructure, announced a strategic partnership with Data Specialties Inc. (DSI) to supply pre-manufactured modular data centers for its SkyMod platform. DSI, based in Buena Park, California, brings over 30 years of mission-critical data center expertise, enabling BluSky to rapidly deploy its SkyMod One (1.0 MW) and SkyMod XL (1.7 MW) units nationwide. The collaboration will support BluSky AI’s goal of exceeding 100 MW of operational capacity within 24 months, delivering scalable, high-performance compute environments for AI developers, enterprises and research institutions. To view the full press release, visit https://nnw.fm/6nA8O About…

Continue Reading

TuesdayJul 15, 2025 12:24 pm

NetworkNewsBreaks – Unusual Machines, Inc. (NYSE American: UMAC) Announces $48.5 Million Registered Direct Offering to Fund U.S. Manufacturing Expansion

Unusual Machines (NYSE American: UMAC), a drone technology and component manufacturing company, has entered into a securities purchase agreement with investors for a registered direct offering of 5 million shares of common stock (or pre-funded warrants) at $9.70 per share. The Offering, expected to close on or about July 15, 2025, will generate approximately $48.5 million in gross proceeds before fees and expenses. Dominari Securities LLC is acting as exclusive placement agent. Proceeds will support U.S.-based manufacturing growth, working capital, and general corporate purposes. To view the full press release, visit https://nnw.fm/s3J5c About Unusual Machines, Inc. Unusual Machines, Inc. manufactures…

Continue Reading

TuesdayJul 15, 2025 11:58 am

NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Strategic Awareness Campaign Ahead of IzoView Breast CT Commercialization

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on advanced breast cancer imaging, has launched a strategic awareness campaign in preparation for the commercialization of its IzoView Breast CT Imaging System. The initiative includes targeted news updates, a new podcast series, and the launch of breastct.com to educate and engage global audiences on IzoView’s patented hardware, AI-driven software, and competitive advantages over traditional imaging. These efforts support Izotropic’s regulatory and go-to-market strategies, aligning investor and market engagement ahead of its anticipated launch. To view the full press release, visit https://nnw.fm/mtCNz About Izotropic More information about Izotropic…

Continue Reading

TuesdayJul 15, 2025 11:24 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Rebrand as Bollinger Innovations, Consolidate Operations for Efficiency and Growth

Mullen Automotive (NASDAQ: MULN), an emerging EV manufacturer, announced it will rebrand as Bollinger Innovations and expects to change its NASDAQ ticker symbol before August 15, 2025. The company is consolidating operations under the Bollinger brand, moving commercial vehicle functions to Oak Park, Michigan, and unifying sales, marketing and service divisions. Since January, Mullen has cut 155 positions and slashed annual operating expenses by at least $35 million. The streamlining aims to improve fiscal efficiency while advancing Class 1, 3 and 4 commercial EVs, including the Mullen ONE and THREE and the Bollinger B4, which boasts a 7,325-lb payload and…

Continue Reading

TuesdayJul 15, 2025 11:20 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Launches AI Module to Accelerate Development of Targeted Cancer Combination Therapies

Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug developer, announced the launch of a new AI-powered module within its RADR(R) platform to predict the efficacy of combination therapies involving DNA-damaging agents (DDAs) and DNA damage response inhibitors (DDRis). Backed by a peer-reviewed analysis of 221 clinical trials, the tool enables precise, biomarker-guided design of cancer treatment regimens, reducing development time and cost by up to one-third. The platform guided the design of Lantern’s FDA-cleared Phase 1B/2 trial in triple-negative breast cancer combining LP-184 and olaparib. Lantern is exploring licensing and commercialization opportunities to scale the system across oncology indications. To…

Continue Reading

TuesdayJul 15, 2025 10:36 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Reinvents Mining Model With Low-Capex Tailings Strategy and Near-Term Production 

ESGold (CSE: ESAU) (OTCQB: ESAUF) a forward-looking mineral resource company, is challenging the traditional high-risk, high-capex mining model by redeveloping legacy mine sites with known volumes, historical grades and existing infrastructure. With its Montauban Project in Quebec now fully permitted and under construction, ESGold is poised for near-term gold, silver and mica production through clean, gravity-based tailings processing. The company has developed a scalable, repeatable cash-flow model that minimizes environmental impact and funds systematic exploration of legacy sites. Led by newly appointed CEO Gordon Robb, ESGold aims to transform forgotten assets into clean, cash-generating producers. As gold prices hit record…

Continue Reading

TuesdayJul 15, 2025 9:40 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) to Launch AI-Integrated Culinary School With Majority Stake in Modern Culinary Systems

Nightfood Holdings (OTCQB: NGTF), through subsidiary Future Hospitality Ventures Holdings Inc. (FHVH), announced a binding LOI with Stratford Education Group, dba Los Angeles Cooking School, to form Modern Culinary Systems Inc. FHVH will hold a 51% stake and invest up to $150,000 over 18 months to drive AI automation and growth. The new venture aims to become the first U.S. culinary school to integrate AI into its curriculum, targeting a $32.5 billion market. FHVH will oversee operations and hold exclusive rights to acquire 100% of Stratford and LACS within 24 months at a 30% discount. To view the full press…

Continue Reading